SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Andreasson Rolf) "

Sökning: WFRF:(Andreasson Rolf)

  • Resultat 1-10 av 20
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  • Andréasson, Maia, 1960, et al. (författare)
  • Swedish CLARIN activities
  • 2009
  • Ingår i: Proceedings of the Nodalida 2009 workshop on CLARIN activities in the Nordic countries. NEALT Proceedings Series. - 1736-6305. ; 5, s. 1-5
  • Konferensbidrag (refereegranskat)
  •  
4.
  • Andréasson, Maia, et al. (författare)
  • Swedish CLARIN Activities
  • 2009
  • Ingår i: Proceedings of the NODALIDA 2009 workshop Nordic Perspectives on the CLARIN Infrastructure of Language Resources. - : Northern European Association for Language Technology (NEALT). ; , s. 1-5
  • Konferensbidrag (refereegranskat)abstract
    • Although Sweden has yet to allocate funds specifically intended for CLARIN activities, there are some ongoing activities which are directly relevant to CLARIN, and which are explicitly linked to CLARIN. These activities have been funded by the Committee for Research Infrastructures and its subcommittee DISC (Database Infrastructure Committee) of the Swedish Research Council.
  •  
5.
  • Andreasson, Rolf, et al. (författare)
  • Solvability of Monge-Ampère equations and tropical affine structures on reflexive polytopes
  • Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
    • Given a reflexive polytope with a height function, we prove a necessary and sufficient condition for solvability of the associated Monge-Ampère equation. When the polytope is Delzant, solvability of this equation implies the metric SYZ conjecture for the corresponding family of Calabi-Yau hypersurfaces. We show how the location of the singularities in the tropical affine structure is determined by the PDE in the spirit of a free boundary problem and give positive and negative examples, demonstrating subtle issues with both solvability and properties of the singular set. We also improve on existing results regarding the SYZ conjecture for the Fermat family by showing regularity of the limiting potential.
  •  
6.
  • Bjerke, Maria, 1977, et al. (författare)
  • Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.
  • 2010
  • Ingår i: International journal of Alzheimer's disease. - : Hindawi Limited. - 2090-0252. ; 2010
  • Tidskriftsartikel (refereegranskat)abstract
    • Background. Patients afflicted with Alzheimer's disease (AD) exhibit a decrease in the cerebrospinal fluid (CSF) concentration of the 42 amino acid form of beta-amyloid (Abeta(42)). However, a high discrepancy between different centers in measured Abeta(42) levels reduces the utility of this biomarker as a diagnostic tool and in monitoring the effect of disease modifying drugs. Preanalytical and analytical confounding factors were examined with respect to their effect on the measured Abeta(42) level. Methods. Aliquots of CSF samples were either treated differently prior to Abeta(42) measurement or analyzed using different commercially available xMAP or ELISA assays. Results. Confounding factors affecting CSF Abeta(42) levels were storage in different types of test tubes, dilution with detergent-containing buffer, plasma contamination, heat treatment, and the origin of the immunoassays used for quantification. Conclusion. In order to conduct multicenter studies, a standardized protocol to minimize preanalytical and analytical confounding factors is warranted.
  •  
7.
  • Bjersand, Kathrine, et al. (författare)
  • Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
  • 2015
  • Ingår i: Annals of Surgical Oncology. - : Springer Science and Business Media LLC. - 1068-9265 .- 1534-4681. ; 22, s. S810-S816
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) is an established therapy for pseudomyxoma peritonei (PMP). However, the role of IPC is unclear. By ex vivo assessment of PMP tumor cell sensitivity to cytotoxic drugs, we investigated the basis for IPC drug selection and the role of IPC in the management of PMP.METHODS: Tumor cells were prepared by collagenase digestion of tumor tissue from 133 PMP patients planned for CRS and IPC. Tumor cell sensitivity to oxaliplatin, 5FU, mitomycin C, doxorubicin, irinotecan, and cisplatin was assessed in a 72-h cell-viability assay. Drug sensitivity was correlated to progression-free survival (PFS) and overall survival (OS).RESULTS: Samples from 92 patients were analyzed successfully. Drug sensitivity varied considerably between samples. Peritoneal mucinous carcinomatosis (PMCA), compared with PMCA intermediate or disseminated peritoneal adenomucinosis, was slightly more resistant to platinum and 5FU and tumor cells from patients previously treated with chemotherapy were generally less sensitive than those from untreated patients. Multivariate analysis showed patient performance status and completeness of CRS to be prognostic for OS. Among patients with complete CRS (n = 61), PFS tended to be associated with sensitivity to mitomycin C and cisplatin (p ≈ 0.06). At the highest drug concentration tested, the hazard ratio for disease relapse increased stepwise with drug resistance for all drugs.CONCLUSIONS: Ex vivo assessment of drug sensitivity in PMP provides prognostic information. The results suggest a role for IPC as therapeutic adjunct to CRS and for individualization of IPC by pretreatment assessment of drug sensitivity.
  •  
8.
  • Constantinescu, Radu, 1966, et al. (författare)
  • Proteomic profiling of cerebrospinal fluid in parkinsonian disorders.
  • 2010
  • Ingår i: Parkinsonism & related disorders. - : Elsevier BV. - 1873-5126 .- 1353-8020. ; :16, s. 545-49
  • Tidskriftsartikel (refereegranskat)abstract
    • Parkinson's disease (PD) and atypical parkinsonian disorders (APD), including multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD), are a group of neurodegenerative diseases sharing many similar signs and symptoms but distinguished by their particular clinical features, treatment response, prognosis and mortality. The differential diagnosis may be challenging, especially in early disease stages. Considering the importance of an accurate diagnosis both for clinical management and for research, new diagnostic tools are needed. In this study, we investigated 56 PD, 42 MSA, 39 PSP, 9 CBD patients, and 24 healthy controls. After screening the cerebrospinal fluid (CSF) proteome using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS), we identified 4 proteins (ubiquitin [mass-to-charge ratio (m/z) 8590], beta2-microglobulin [m/z 11730], and 2 secretogranin 1 [chromogranin B] fragments [m/z 7260 and m/z 6250]) that differentiated healthy controls and PD patients from patients with APD. However, they could not differentiate PD patients from controls. As none of these changes were APD subgroup-specific, they most likely reflect the intensity and/or extent of the neurodegenerative process in general.
  •  
9.
  • Ekeberg, Tomas, 1983-, et al. (författare)
  • Three-dimensional structure determination with an X-ray laser
  • Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
    • Three-dimensional structure determination of a non-crystalline virus has been achieved from a set of randomly oriented continuous diffraction patterns captured with an X-ray laser. Intense, ultra-short X-ray pulses intercepted a beam of single mimivirus particles, producing single particle X-ray diffraction patterns that are assembled into a three-dimensional amplitude distribution based on statistical consistency. Phases are directly retrieved from the assembled Fourier distribution to synthesize a three-dimensional image. The resulting electron density reveals a pseudo-icosahedral asymmetric virion structure with a compartmentalized interior, within which the DNA genome occupies only about a fifth of the volume enclosed by the capsid. Additional electron microscopy data indicate the genome has a chromatin-like fiber structure that has not previously been observed in a virus. 
  •  
10.
  • Hagström, Hannes, et al. (författare)
  • Overweight in late adolescence predicts development of severe liver disease later in life : A 39 years follow-up study
  • 2016
  • Ingår i: Journal of Hepatology. - : Elsevier BV. - 0168-8278 .- 1600-0641. ; 65:2, s. 363-368
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND & AIMS: The increased prevalence of overweight has been suggested to contribute to the worldwide increase in liver diseases. We investigated if body mass index (BMI) in late adolescence predicts development of severe liver disease later in life.METHODS: We performed a cohort study using data from 44,248 men (18-20years) conscribed to military service in Sweden between 1969 and 1970. Outcome data were collected from national registers to identify any diagnosis of severe liver disease (i.e., diagnosis of decompensated liver disease, cirrhosis or death in liver disease) until the end of 2009. A Cox regression model was applied using BMI as independent variable. The model was adjusted for use of alcohol, use of narcotics, smoking, high blood pressure and cognitive ability at time of conscription.RESULTS: During a follow-up period of a mean of 37.8years, 393 men were diagnosed with severe liver disease (mean time to diagnosis 24.7years). BMI (Hazard ratio [HR]=1.05 for each unit increase in BMI, 95% confidence interval [CI]: 1.01-1.09, p=0.008) and overweight (HR=1.64 for BMI 25-30 compared to BMI 18.5-22.5, 95% CI: 1.16-2.32, p=0.006) were associated with an increased risk of development of severe liver disease.CONCLUSIONS: Being overweight in late adolescence is a significant predictor of severe liver disease later in life in men.LAY SUMMARY: We investigated close to 45,000 Swedish men in their late teens enlisted for conscription in 1969-1970. After almost 40years of follow-up, we found that being overweight was a risk factor for developing severe liver disease, independent of established risk factors such as alcohol consumption.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 20
Typ av publikation
tidskriftsartikel (13)
bok (2)
annan publikation (2)
konferensbidrag (2)
rapport (1)
Typ av innehåll
refereegranskat (14)
övrigt vetenskapligt/konstnärligt (6)
Författare/redaktör
Blennow, Kaj, 1958 (4)
Zetterberg, Henrik, ... (4)
Anckarsäter, Henrik, ... (4)
Wallin, Anders, 1950 (2)
Hultcrantz, Rolf (2)
Beskow, Jonas (2)
visa fler...
Andreasson, Anna (2)
Merkel, Magnus (2)
Edlund, Jens (2)
House, David (2)
Aquila, Andrew (2)
Fladby, T (1)
Eriksson, Anders, 19 ... (1)
Eriksson, Anders (1)
Larsson, Rolf (1)
Axelsson, M. (1)
Carlsson, Gunilla (1)
Hagberg, Lars, 1951 (1)
Rosengren, Lars, 195 ... (1)
Hesse, Camilla (1)
Fredrikson, S (1)
Lycke, Jan, 1956 (1)
Stål, Per (1)
Halfvarson, Jonas, 1 ... (1)
Carlson, Kristina (1)
Borin, Lars, 1957 (1)
Forsberg, Markus, 19 ... (1)
Tarkowski, Andrej, 1 ... (1)
Holmberg, Erik, 1951 (1)
Nygren, Peter (1)
Andréasson, Maia (1)
Wikkelsö, Carsten, 1 ... (1)
Constantinescu, Radu ... (1)
Portelius, Erik, 197 ... (1)
Ohlsson, Bodil (1)
Agréus, Lars (1)
Forsberg, Markus (1)
Andersen, Oluf, 1941 (1)
Haghighi, Sara (1)
Lekander, Mats (1)
Andréasson, Björn (1)
Kecklund, Göran (1)
Sakdinawat, Anne (1)
Hagström, Hannes (1)
Axelsson, J (1)
Ingre, Michael (1)
Sundström Poromaa, I ... (1)
Billström, Rolf (1)
Padyukov, Leonid (1)
Almer, Sven (1)
visa färre...
Lärosäte
Göteborgs universitet (11)
Uppsala universitet (6)
Karolinska Institutet (6)
Umeå universitet (2)
Stockholms universitet (2)
Lunds universitet (2)
visa fler...
Mälardalens universitet (1)
Örebro universitet (1)
Linköpings universitet (1)
visa färre...
Språk
Engelska (18)
Svenska (2)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (10)
Naturvetenskap (5)
Samhällsvetenskap (2)
Humaniora (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy